Related references
Note: Only part of the references are listed.Infantile inflammatory myofibroblastic tumors: clinicopathological and molecular characterization of 12 cases
Oscar Lopez-Nunez et al.
MODERN PATHOLOGY (2020)
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials
Robert C. Doebele et al.
LANCET ONCOLOGY (2020)
High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden
Ryma Benayed et al.
CLINICAL CANCER RESEARCH (2019)
DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer
Kurtis D. Davies et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations
Yoshiyuki Suehara et al.
CLINICAL CANCER RESEARCH (2019)
Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation
Fabienne Hamester et al.
BRITISH JOURNAL OF CANCER (2019)
Discovery and Characterization of Recurrent, Targetable ALK Fusions in Leiomyosarcoma
Lara E. Davis et al.
MOLECULAR CANCER RESEARCH (2019)
ROS1-GOPC/FIG: a novel gene fusion in hepatic angiosarcoma
Eric I. Marks et al.
Oncotarget (2019)
Next-Generation Sequencing for Patients with Sarcoma: A Single Center Experience
Gregory M. Cote et al.
ONCOLOGIST (2018)
Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancer
Karen Legler et al.
BRITISH JOURNAL OF CANCER (2018)
Development and Evaluation of a Pan-Sarcoma Fusion Gene Detection Assay Using the NanoString nCounter Platform
Kenneth T. E. Chang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2018)
Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples
Kurtis D. Davies et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
A. Drilon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Integrative genomic and transcriptomic analysis of leiomyosarcoma
Priya Chudasama et al.
NATURE COMMUNICATIONS (2018)
NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano Cocco et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas
Alexander J. Lazar et al.
CELL (2017)
Targeted Exome Sequencing Profiles Genetic Alterations in Leiomyosarcoma
Narasimhan P. Agaram et al.
GENES CHROMOSOMES & CANCER (2016)
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group
A. Gronchi et al.
ANNALS OF ONCOLOGY (2016)
ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours
Hidetaka Yamamoto et al.
HISTOPATHOLOGY (2016)
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology
Donavan T. Cheng et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Cabozantinib Overcomes Crizotinib Resistance in ROS1 Fusion-Positive Cancer
Ryohei Katayama et al.
CLINICAL CANCER RESEARCH (2015)
Crizotinib in ROS1-Rearranged Non-Small-Cell Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Molecular Pathways: ROS1 Fusion Proteins in Cancer
Kurtis D. Davies et al.
CLINICAL CANCER RESEARCH (2013)
Breakpoint Analysis of Transcriptional and Genomic Profiles Uncovers Novel Gene Fusions Spanning Multiple Human Cancer Types
Craig P. Giacomini et al.
PLOS GENETICS (2013)
Identification of KIF5B-RET and GOPC-ROS1 Fusions in Lung Adenocarcinomas through a Comprehensive mRNA-Based Screen for Tyrosine Kinase Fusions
Yoshiyuki Suehara et al.
CLINICAL CANCER RESEARCH (2012)
Proteomic analysis of soft tissue sarcoma
Yoshiyuki Suehara
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2011)
Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity
Frederic Chibon et al.
NATURE MEDICINE (2010)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Share Paper
